Supplementary Tables from A Transcriptionally Definable Subgroup of Triple-Negative Breast and Ovarian Cancer Samples Shows Sensitivity to HSP90 Inhibition

Table S1. BRCA and OVCA cell lines analyzed. Cell line data were obtained from the GDSC or CCLE databases as indicated. Table S2. Drug sensitivity analysis for BR/OV-1 vs. -2 cell lines in GDSC. Table S3. BR/OV-1/2 gene expression classifier. Table S4. Gene Ontology (GO) analysis for BR/OV-1/2 classifier genes. Table S5. Subtyping of TNBC cell lines. Table S6. Genes upregulated in BR/OV-2 cells are rarely present in reported mesenchymal gene signatures. Table S7. (Phospho)proteins differentially expressed between BR/OV-1 vs. -2 cells by RPPA. Table S8. Proteins differentially expressed between BR/OV-1 and -2 TNBC cells by MS. Table S9. Gene Ontology (GO) analysis of differentially expressed proteins. Table S10. BR/OV-1/2 Subgroup Scores for 88 BRCA PDX models from 20 patients.